Thermo Fisher Scientific has added two mass spectrometers — the Thermo Scientific Orbitrap Exploris 240 and Thermo Scientific Orbitrap Exploris 120 — to its Thermo Scientific Orbitrap Exploris portfolio.
The Thermo Scientific Orbitrap Exploris 240 mass spectrometer boasts the latest generation of system architecture and instrument control software to boost data acquisition and analysis capabilities for small- and large-molecule applications. The system includes positive/negative mode switching for comprehensive sample coverage, fast scan speeds and functionalities including Thermo Scientific AcquireX intelligent data acquisition workflow for greater automation.
“Scientists are seeking technologies that can streamline and speed proteomics studies to clinical applications, reduce time to market for candidate biotherapeutics and address the growing challenge of characterizing novel chemical entities in small-molecule studies,” said Iain Mylchreest, VP of research and development for analytical instruments at Thermo Fisher Scientific.
“As part of our expanded portfolio of new-generation instruments, the Orbitrap Exploris 240 mass spectrometer delivers the high performance and versatility needed to drive productivity across multiple applications,” Mylchreest said in a news release yesterday.
The Thermo Scientific Orbitrap Exploris 120 mass spectrometer meanwhile has fast scanning modes and rapid polarity switching that result in comprehensive sample coverage and increased productivity, according to Thermo Fisher Scientific. It delivers benefits for high-throughput screening and quantitation assays, according to the company
“Scientists running small molecule studies and applications in areas such as metabolomics, environmental analysis, metabolite identification, forensic toxicology, and anti-doping, require complete sample coverage in their analyses, without compromising productivity,” said August Specht, VP of research and development for chromatography and mass spectrometry at Thermo Fisher Scientific.
“The Orbitrap Exploris 120 mass spectrometer was designed specifically for laboratories to safeguard their current assays and enhance their provision of high-throughput and differentiated services, while simultaneously minimizing required training and method development times,” Specht said.
Thermo Fischer is showcasing the new systems at its virtual event, vLC-MS, being held May 26–28, 2020, and the American Society for Mass Spectrometry (ASMS) Reboot Program scheduled June 1–12, 2020.
Other announcements related to the virtual event include next-generation analytical software to strengthen data exploration, a collaboration with MSAID to provide access to deep learning tools for discovery and targeted proteomics, and an extended collaboration with Biognosys to enhance protein quantitation mass spectrometry workflows.
Filed Under: Drug Discovery and Development
